13F HOLDINGS REPORT
REGENERON PHARMACEUTICALS, INC.
Quarter ended Q4 2024 · Filed February 7, 2025 · Accession 0001104659-25-010583
Total Value
$1.09B
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals, Inc. | ALNY | 4,444,445 | $1.05B | 95.54% |
| 2 | Intellia Therapeutics, Inc. | NTLA | 3,702,995 | $43.2M | 3.94% |
| 3 | 2seventy bio, Inc. | 901384107 | 1,254,827 | $3.7M | 0.34% |
| 4 | Adicet Bio, Inc. | ACET | 968,183 | $931,392 | 0.09% |
| 5 | Adverum Biotechnologies, Inc. | 00773U207 | 180,909 | $844,845 | 0.08% |
| 6 | bluebird bio, Inc. | 09609G209 | 21,000 | $175,140 | 0.02% |